USANA Health Sciences, Inc (USNA) is a leading household and personal products business based in the US. It opened the day at $101.74 after a previous close of $102.84. During the day the price has varied from a low of $101.285 to a high of $102.54. The latest price was $101.695 (25 minute delay). USANA Health Sciences is listed on the NYSE and employs 1,943 staff. All prices are listed in US Dollars.
Since the stock market crash that started in February 2020, USANA Health Sciences's share price has had significant positive movement.
Its last market close was $105.3, which is 33.09% up on its pre-crash value of $70.46 and 144.83% up on the lowest point reached during the March 2020 crash when the shares fell as low as $43.01.
If you had bought $1,000 worth of USANA Health Sciences shares at the start of February 2020, those shares would have been worth $798.42 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,671.11.
|52-week range||$68.3 - $107.85|
|50-day moving average||$100.6263|
|200-day moving average||$92.2297|
|Wall St. target price||$115|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$6.085|
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-06-08)||-1.56%|
|1 month (2021-05-18)||1.36%|
|3 months (2021-03-18)||3.26%|
|6 months (2020-12-18)||28.94%|
|1 year (2020-06-18)||28.42%|
|2 years (2019-06-18)||36.58%|
|3 years (2018-06-18)||-14.51%|
|5 years (2016-06-17)||80.90%|
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
USANA Health Sciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, USANA Health Sciences shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
USANA Health Sciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0695. A PEG ratio close to 1 can be interpreted as meaning shares offer reasonable value for the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into USANA Health Sciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
USANA Health Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $195.2 million.
The EBITDA is a measure of a USANA Health Sciences's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.2 billion|
|Operating margin TTM||15.45%|
|Gross profit TTM||$925.5 million|
|Return on assets TTM||21.46%|
|Return on equity TTM||35.74%|
|Market capitalisation||$2.1 billion|
TTM: trailing 12 months
There are currently 615,994 USANA Health Sciences shares held short by investors – that's known as the "short interest". This figure is 5.1% down from 649,200 last month.
There are a few different ways that this level of interest in shorting USANA Health Sciences shares can be evaluated.
USANA Health Sciences's "short interest ratio" (SIR) is the quantity of USANA Health Sciences shares currently shorted divided by the average quantity of USANA Health Sciences shares traded daily (recently around 111593.11594203). USANA Health Sciences's SIR currently stands at 5.52. In other words for every 100,000 USANA Health Sciences shares traded daily on the market, roughly 5520 shares are currently held short.
However USANA Health Sciences's short interest can also be evaluated against the total number of USANA Health Sciences shares, or, against the total number of tradable USANA Health Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case USANA Health Sciences's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 USANA Health Sciences shares in existence, roughly 30 shares are currently held short) or 0.0578% of the tradable shares (for every 100,000 tradable USANA Health Sciences shares, roughly 58 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against USANA Health Sciences.
Find out more about how you can short USANA Health Sciences stock.
We're not expecting USANA Health Sciences to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
USANA Health Sciences's shares were split on a 2:1 basis on 23 November 2016. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your USANA Health Sciences shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for USANA Health Sciences shares which in turn could have impacted USANA Health Sciences's share price.
Over the last 12 months, USANA Health Sciences's shares have ranged in value from as little as $68.3 up to $107.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while USANA Health Sciences's is 0.9201. This would suggest that USANA Health Sciences's shares are less volatile than average (for this exchange).
This guide will show you step-by-step instructions on how to buy the TitanSwap (TITAN) token as well as a list of exchanges you can trade it on.
AMC Entertainment Shares surpassed $50 last week to be up more than 2,000% this year, replacing GameStop as Reddit investors most beloved meme stock.
We used ADAC safety testing data to compare the 10 best child car seats to buy in the UK for 2021. Compare price, weight and safety features.
20% of British adults plan to shop the Amazon Prime Day 2021 sales, according to the latest statistics from Finder’s Amazon Prime Day shopping report.
Does Apple have a back-to-school sale in the UK? Find out when the deals start and what to expect from this year’s Apple sale.
Shares in AMC Entertainment Holdings are again closing in on their all-time high. The cinema operator has jumped 111% in the past 5 sessions alone. Find out what’s going on with this “meme stock”.
See if you can get your next Secret Sales order for less with our hand-tested voucher and promo codes.
Find out the difference between a credit score and a credit report as well as what factors can bring it up and down?
This guide will show you step-by-step instructions on how to buy the SafeMoon (SAFEMOON) token as well as a list of exchanges you can trade it on.
This guide will show you step-by-step instructions on how to buy the Shiba Inu (SHIB) token as well as a list of exchanges you can trade it on.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.